IBDEI1TR ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29153,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,29153,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,29153,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,29154,0)
 ;;=F03.91^^118^1464^16
 ;;^UTILITY(U,$J,358.3,29154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29154,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,29154,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,29154,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,29155,0)
 ;;=F03.90^^118^1464^18
 ;;^UTILITY(U,$J,358.3,29155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29155,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,29155,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,29155,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,29156,0)
 ;;=G31.84^^118^1464^23
 ;;^UTILITY(U,$J,358.3,29156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29156,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,29156,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,29156,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,29157,0)
 ;;=F02.81^^118^1464^14
 ;;^UTILITY(U,$J,358.3,29157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29157,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
 ;;^UTILITY(U,$J,358.3,29157,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,29157,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,29158,0)
 ;;=F02.80^^118^1464^15
 ;;^UTILITY(U,$J,358.3,29158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29158,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/o Behav Dist
 ;;^UTILITY(U,$J,358.3,29158,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,29158,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,29159,0)
 ;;=A81.01^^118^1464^9
 ;;^UTILITY(U,$J,358.3,29159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29159,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,29159,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,29159,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,29160,0)
 ;;=F05.^^118^1464^13
 ;;^UTILITY(U,$J,358.3,29160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29160,1,3,0)
 ;;=3^Delirium d/t Physiological Cond
 ;;^UTILITY(U,$J,358.3,29160,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,29160,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,29161,0)
 ;;=R41.0^^118^1464^19
 ;;^UTILITY(U,$J,358.3,29161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29161,1,3,0)
 ;;=3^Disorientation,Unspec
 ;;^UTILITY(U,$J,358.3,29161,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,29161,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,29162,0)
 ;;=G31.09^^118^1464^20
 ;;^UTILITY(U,$J,358.3,29162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29162,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,29162,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,29162,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,29163,0)
 ;;=G90.3^^118^1464^24
 ;;^UTILITY(U,$J,358.3,29163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29163,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,29163,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,29163,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,29164,0)
 ;;=A81.9^^118^1464^28
 ;;^UTILITY(U,$J,358.3,29164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29164,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,29164,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,29164,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,29165,0)
 ;;=S06.2X9S^^118^1464^31
